Salvat
5 in Phase 3
Quick facts
Phase 3 pipeline
- DF277 · Diabetes
DF277 is a small molecule drug that targets the SGLT2 receptor. - DF289
DF289 is a small molecule that targets the [unknown molecular target] to [unknown therapeutic effect]. - DF289 plus DF277
DF289 plus DF277 is a fixed-dose combination targeting multiple pathways in inflammatory or metabolic disease. - G238
G238 is a small molecule that targets the [unknown] mechanism to treat [unknown] conditions. - SVT-15652 · Cardiovascular
SVT-15652 is a small molecule that targets the cardiac sodium channel.
Phase 2 pipeline